Trials / Recruiting
RecruitingNCT03022552
Heart Attack Research Program: Platelet Sub-Study (HARP)
Heart Attack Research Program: Platelet Sub-Study (HARP); Platelet Collection for Patients With Myocardial Infarction
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- Female
- Age
- 21 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
This prospective observational cohort study, will investigate the platelet phenotype, platelet genetic composition, and role of platelets as effector cells in women and men with myocardial infarction (MINOCA or MI-CAD) and controls. This study, which will take place at NYU and Bellevue Medical Center, and participating external sites. May have concurrent enrollment with the HARP Main Imaging (NCT02914483). Additionally, a sex, group of age and race matched disease controls 'CATH-NOCA' composed of women and men with stable angina referred for cardiac catheterization, will be enrolled. Blood obtained during the initial catheterization and 2 months post-MI will be utilized for platelet testing.
Conditions
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2017-01-16
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03022552. Inclusion in this directory is not an endorsement.